205 related articles for article (PubMed ID: 21737610)
1. Therapy-, gender- and race-specific microRNA markers, target genes and networks related to glioblastoma recurrence and survival.
Delfino KR; Serão NV; Southey BR; Rodriguez-Zas SL
Cancer Genomics Proteomics; 2011; 8(4):173-83. PubMed ID: 21737610
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival.
Serão NV; Delfino KR; Southey BR; Beever JE; Rodriguez-Zas SL
BMC Med Genomics; 2011 Jun; 4():49. PubMed ID: 21649900
[TBL] [Abstract][Full Text] [Related]
3. Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.
Ilhan-Mutlu A; Wöhrer A; Berghoff AS; Widhalm G; Marosi C; Wagner L; Preusser M
J Neurooncol; 2013 May; 112(3):347-54. PubMed ID: 23420397
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-target cross-talks: Key players in glioblastoma multiforme.
Toraih EA; Aly NM; Abdallah HY; Al-Qahtani SA; Shaalan AA; Hussein MH; Fawzy MS
Tumour Biol; 2017 Nov; 39(11):1010428317726842. PubMed ID: 29110584
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence.
Delfino KR; Rodriguez-Zas SL
PLoS One; 2013; 8(3):e58608. PubMed ID: 23554906
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme.
Zhang W; Zhang J; Yan W; You G; Bao Z; Li S; Kang C; Jiang C; You Y; Zhang Y; Chen CC; Song SW; Jiang T
Cancer; 2013 Feb; 119(4):814-24. PubMed ID: 22990979
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of microRNA-221/2 and 17-92 Families in Primary Glioblastoma Patients Treated with Postoperative Radiotherapy.
Schnabel E; Knoll M; Schwager C; Warta R; Mock A; Campos B; König L; Jungk C; Wick W; Unterberg A; Debus J; Herold-Mende C; Abdollahi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803955
[TBL] [Abstract][Full Text] [Related]
9. Serum microRNA profiling in patients with glioblastoma: a survival analysis.
Zhao H; Shen J; Hodges TR; Song R; Fuller GN; Heimberger AB
Mol Cancer; 2017 Mar; 16(1):59. PubMed ID: 28284220
[TBL] [Abstract][Full Text] [Related]
10. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.
Qiu S; Lin S; Hu D; Feng Y; Tan Y; Peng Y
J Transl Med; 2013 Jan; 11():10. PubMed ID: 23302469
[TBL] [Abstract][Full Text] [Related]
11. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
12. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
13. Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.
Wei X; Zhang QM; Liu C; Wu S; Nong WX; Ge YY; Lin LN; Li F; Xie XX; Luo B
Curr Med Sci; 2022 Jun; 42(3):584-596. PubMed ID: 35678909
[TBL] [Abstract][Full Text] [Related]
14. Hsa-miR-27a-3p and epidermal growth factor receptor expression analysis in glioblastoma FFPE samples.
Salmani T; Ghaderian SMH; Hajiesmaeili M; Rezaeimirghaed O; Hoseini MS; Rakhshan A; Nasiri MJ; Ghaedi H; Akbarzadeh R
Asia Pac J Clin Oncol; 2021 Oct; 17(5):e185-e190. PubMed ID: 33029912
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
16. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
17. MiR-106a is an independent prognostic marker in patients with glioblastoma.
Zhao S; Yang G; Mu Y; Han D; Shi C; Chen X; Deng Y; Zhang D; Wang L; Liu Y; Hou X; Wang C; Wu J; Liu H; Wang L; Zhang G; Qi J; Fang X; Shi C; Ai J
Neuro Oncol; 2013 Jun; 15(6):707-17. PubMed ID: 23416698
[TBL] [Abstract][Full Text] [Related]
18. Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.
Shahar T; Granit A; Zrihan D; Canello T; Charbit H; Einstein O; Rozovski U; Elgavish S; Ram Z; Siegal T; Lavon I
J Neurooncol; 2016 Dec; 130(3):413-422. PubMed ID: 27573219
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression.
Li Y; Xu J; Chen H; Bai J; Li S; Zhao Z; Shao T; Jiang T; Ren H; Kang C; Li X
Nucleic Acids Res; 2013 Dec; 41(22):e203. PubMed ID: 24194606
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic effects of miR-10b in glioblastoma stem cells.
Guessous F; Alvarado-Velez M; Marcinkiewicz L; Zhang Y; Kim J; Heister S; Kefas B; Godlewski J; Schiff D; Purow B; Abounader R
J Neurooncol; 2013 Apr; 112(2):153-63. PubMed ID: 23307328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
